ACR Convergence 2025 On Demand
$139900
ACRCVG25-OD
Self-Paced
Basic & Clinical Sciences, Crystal-Induced Arthropathies, Healthcare Disparities, Infections & Related Arthritides, Inflammatory Myopathies, Lupus, Metabolic Bone Disease, Nonarticular & Regional Musculoskeletal Disorders, Osteoarthritis & Related Disorders, Other Rheumatic & Connective Tissue Disorders, Pain Syndromes, Patient Communication, Pediatric, Quality Measures, Reproductive Health, Research Methodology, Rheumatoid Arthritis, Spondyloarthropathies, Vasculitides
Thursday, November 13, 2025, 12:00 AM
Saturday, October 24, 2026, 11:55 PM
CME, ABIM MOC, ABP MOC, Participation
Advanced Practice Nurses, Counselors, Dieticians, Division Directors, Fellows in Training, Health Services Researchers, Nurses, Occupational Therapists, Pharmacists, Practice Administrators, Primary Care Providers, Physical Therapists, Physician Assistants, Psychologists, Researchers, Rheumatologists, Rheumatology Interprofessionals, Social Workers / Community Health Workers, Students, Program Directors
210.00
210.00
210.00

Activity Overview

ACR Convergence 2025 On Demand features recorded sessions from the premier international rheumatology meeting that took place in Chicago, Illinois. See cutting-edge insights across basic and clinical science with flexible, self-paced access to plenaries and symposia. 


Target Audience

Advanced practice nurses, counselors, dietitians, division directors, epidemiologists, fellows in training, health service researchers, nurses, occupational therapists, office managers/staff, pharmacists, practice administrators, primary care providers, physical therapists, physician associates, program directors, psychologists, researchers, residents, rheumatologists, rheumatology interprofessionals, social workers / community health workers, and students.

Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess their knowledge and competence in various rheumatic diseases and conditions
  • Support their skills in evaluating and diagnosing patients with rheumatic diseases
  • Discuss and collaborate on challenging cases with peers
  • Analyze emerging trends and technologies in rheumatology
  • Employ evidence-based approaches for managing rheumatic conditions
  • Identify new approaches and strategies for patient management
  • Interpret recent clinical trial and research findings
  • Apply new information from basic and clinical science to improve the care of people with rheumatologic illness

 

CME

ACCME Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.


AMA Designation Statement

The American College of Rheumatology designates this Enduring Material for a maximum of 210.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credit must be claimed by October 24, 2026, at 11:59 PM ET.


MOC

MOC Recognition Statement: American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 210.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. 

After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by October 24, 2026, at 11:59 PM ET.

abim logo


MOC Recognition Statement: American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 210.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal. 

MOC points must be claimed by October 24, 2026, at 11:59 PM ET.


Financial Relationship Disclosures

ACR Disclosure Statement

It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.


Nature of Financial Relationships

All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

  1. Advisor or review panel member
  2. Consultant
  3. Employee
  4. Officer or Board Member
  5. Grant/research support
  6. Speaker/honoraria includes speaker’s bureau, symposia, and expert witness
  7. Independent contractor
  8. Executive role and/or ownership interest
  9. Royalties and/or patent beneficiary
  10. Intellectual property/patents
  11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  12. Private investigator
  13. Expert witness
  14. Equity interest
  15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. ACR Convergence 2025 On Demand Financial Relationship Disclosures


Acknowledgement of Commercial Support

No commercial support was provided for this activity.


Educational Activity Policies

See ACR educational activity policies, including the online enduring activity refund policy.

ACR Convergence 2025 On Demand

ACR Convergence 2025 On Demand features recorded sessions from the premier international rheumatology meeting that took place in Chicago, Illinois. See cutting-edge insights across basic and clinical science with flexible, self-paced access to plenaries and symposia.